Caladrius Biosciences (CLBS) Investor Presentation - Slideshow

caladrius Developing Regenerative Therapies that Reverse Chronic Disease David J. Mazzo, PhD President & Chief Executive Officer February 25, 2021 | Nasdaq: CLBS Forward-looking statement 2 This Investor Presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this presentation, and involve certain risks and uncertainties. All statements other than state ...